Dr. Michael Zeligs
Michael A. Zeligs, M.D. is the Founder and CEO of BioResponse Nutrients . He is a physician with a M.A. in human physiology and a M.D. from the University of California. Dr. Zeligs returned to UC Irvine to complete a research fellowship in Molecular Immunology. Dr. Zeligs was the first to develop absorbable diindolylmethane (DIM). The clinical study and scientific investigation of microencapsulated DIM has resulted in new uses including promotion of breast, prostate, and immune health.
Dr. Zeligs’ work has encouraged new approaches to hormonal health, cancer prevention, and healthy aging. BioResponse is investigating the health potential of DIM under a clinical trials agreement with the National Cancer Institute (NCI) and collaborating health science centers.
